159
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Idiopathic Hypereosinophilia: A Multicenter Retrospective Analysis

ORCID Icon, , , ORCID Icon, , & show all
Pages 1763-1771 | Received 07 Sep 2022, Accepted 25 Nov 2022, Published online: 10 Dec 2022

References

  • Wang SA. The diagnostic work-up of hypereosinophilia. Pathobiology. 2019;86(1):39–52. doi:10.1159/000489341
  • Roufosse F, Weller PF. Practical approach to the patient with hypereosinophilia. J Allergy Clin Immunol. 2010;126(1):39–44. doi:10.1016/j.jaci.2010.04.011
  • Kahn JE, Groh M, Lefévre G. (A critical appraisal of) classification of hypereosinophilic disorders. Front Med. 2017;4:216. doi:10.3389/fmed.2017.00216
  • Shdid RA, Azrieh B, Alebbi S, Mansour S, Naeem M. Idiopathic hypereosinophilic syndrome with multiple organ involvement. Case Rep Oncol. 2021;14(1):249–255. doi:10.1159/000511396
  • Klion AD. How I treat hypereosinophilic syndromes. Blood. 2015;126(9):1069–1077. doi:10.1182/blood-2014-11-551614
  • Valent P, Klion AD, Horny H-P, et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol. 2012;130(3):607–612. doi:10.1016/j.jaci.2012.02.019
  • Mahajan VK, Singh R, Mehta KS, et al. Idiopathic hypereosinophilic syndrome: a rare cause of erythroderma. J Dermatol Case Rep. 2014;8(4):108–114. doi:10.3315/jdcr.2014.1185
  • Wu P, Chen Y, Zhang H, Li C. Idiopathic hypereosinophilic syndrome presenting with multiple organ damage. Medicine. 2019;98(10):e14532. doi:10.1097/MD.0000000000014532
  • Leru PM. Eosinophilic disorders: evaluation of current classification and diagnostic criteria, proposal of a practical diagnostic algorithm. Leru Clin Transl Allergy. 2019;9:36. doi:10.1186/s13601-019-0277-4
  • Roufosse FE, Goldman M, Cogan E. Hypereosinophilic syndromes. Orphanet J Rare Dis. 2007;2(1):37. doi:10.1186/1750-1172-2-37
  • Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood. 1994;83(10):2759–2779. doi:10.1182/blood.V83.10.2759.2759
  • Helbig G, Hus M, Francuz T, Dziaczkowska-Suszek J, Soja A, Kyrcz-Krzemień S. Characteristics and clinical outcome of patients with hypereosinophilia of undetermined significance. Med Oncol. 2014;31(1):815. doi:10.1007/s12032-013-0815-1
  • Ogbogu PU, Bochner BS, Butterfield JH, et al. Hypereosinophilic syndromes: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol. 2009;124(6):1319–25.e3. doi:10.1016/j.jaci.2009.09.022
  • Helbig G, Wiśniewska-Piąty K, Francuz T, Dziaczkowska-Suszek J, Kyrcz-Krzemień S. Diversity of clinical manifestations and response to corticosteroids for idiopathic hypereosinophilic syndrome: retrospective study in 33 patients. Leuk Lymphoma. 2013;54(4):807–811. doi:10.3109/10428194.2012.731602
  • Butt NM, Lambert J, Ali S, et al. Guideline for the investigation and management of eosinophilia. Br J Haematol. 2017;176(4):553–572. doi:10.1111/bjh.14488
  • Shomali W, Gotlib J. World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management. Am J Hematol. 2019;94(10):1149–1167. doi:10.1002/ajh.25617